By further elucidating the mechanistic roles of the PI3K/AKT/mTOR pathway in cSCC pathogenesis, we anticipate the development of more effective treatment regimens to improve patient prognosis. The gene discussed is MTOR; the disease is skin squamous cell carcinoma.